CMDhCoordination Group for Mutual Recognition and Decentralised procedures – human (CMDh) http://www.hma.eu/cmdh.html"
Cost effectivenessIn the context of pharmacoeconomics, cost effectiveness is studied by looking at the results of different interventions by measuring a single outcome, usually in 'natural' units (for example, life-years gained, deaths avoided, heart attacks avoided, or cases detected).Alternative interventions(...)
CDSPCouncil of Health Ministers (CDSP) http://www.coe.int/t/dg3/health/CDSP_en.asp"
Criteria for 'go/no-go' decisionsCompounds under investigation as potential new medicines must meet certain criteria, at each stage of development, in order to progress further. These criteria need to be agreed upon by the medicines developers. A ‘go’ decision means that the compound meets the criteria, and will be advanced(...)
Cross-Sectional StudyA cross-sectional study is one type of observational study, in which the researcher does not perform any intervention (such as administering a medicine).Cross-sectional studies are primarily used to find out how many cases of a disease are present in a population at a given point in time(...)
